Basic Information
| LncRNA/CircRNA Name | LINC01410 |
| Synonyms | NA |
| Region | GRCh38_9:62801461-62813486 |
| Ensemble | ENSG00000238113 |
| Refseq | NR_121647 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | endometrial cancer |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot, Luciferase reporter assay etc |
| Sample | EC tissues and normal tissues, cell lines (RL95-2, HEC-1-A, KLE) |
| Expression Pattern | up-regulated |
| Function Description | Our results indicated that high expression of LINC01410 promoted EC cell progression through modulating miR-23c/CHD7 axis, providing a new direction for revealing the molecular mechanism of EC. |
| Pubmed ID | 32314193 |
| Year | 2020 |
| Title | LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells. |
External Links
| Links for LINC01410 | GenBank HGNC NONCODE |
| Links for endometrial cancer | OMIM COSMIC |